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Abstract
Background: In recent years, it has been gradually realized that bacterial inclusion bodies (IBs) could be
biologically active. In particular, several proteins including green fluorescent protein, b-galactosidase, b-lactamase,
alkaline phosphatase, D-amino acid oxidase, polyphosphate kinase 3, maltodextrin phosphorylase, and sialic acid
aldolase have been successfully produced as active IBs when fused to an appropriate partner such as the foot-and-
mouth disease virus capsid protein VP1, or the human b-amyloid peptide Ab42(F19D). As active IBs may have
many attractive advantages in enzyme production and industrial applications, it is of considerable interest to
explore them further.
Results: In this paper, we report that an ionic self-assembling peptide ELK16 (LELELKLK)2 was able to effectively
induce the formation of cytoplasmic inclusion bodies in Escherichia coli (E. coli) when attached to the carboxyl
termini of four model proteins including lipase A, amadoriase II, b-xylosidase, and green fluorescent protein. These
aggregates had a general appearance similar to the usually reported cytoplasmic inclusion bodies (IBs) under
transmission electron microscopy or fluorescence confocal microscopy. Except for lipase A-ELK16 fusion, the three
other fusion protein aggregates retained comparable specific activities with the native counterparts.
Conformational analyses by Fourier transform infrared spectroscopy revealed the existence of newly formed
antiparallel beta-sheet structures in these ELK16 peptide-induced inclusion bodies, which is consistent with the
reported assembly of the ELK16 peptide.
Conclusions: This has been the first report where a terminally attached self-assembling b peptide ELK16 can
promote the formation of active inclusion bodies or active protein aggregates in E. coli. It has the potential to
render E. coli and other recombinant hosts more efficient as microbial cell factories for protein production. Our
observation might also provide hints for protein aggregation-related diseases.
Background
Bacteria have long served as cell factories for recombi-
nant protein production, while higher yields of soluble
proteins have always been pursued. However, over-
expression of heterogenous proteins often leads to the
accumulation of insoluble protein aggregates, commonly
known as inclusion bodies (IBs). The accumulation of
IBs has been one main obstacle of recombinant protein
production, as they are often clusters of misfolded poly-
peptides, which are thus disfunctional and undesirable
[1]. However, over the last several years, it is gradually
realized that some IBs could be still biologically active,
without regard to their insolubility [2-4]. Partially active
IBs were first observed for b-galactosidase in 1989 [5],
likely as a result of a small amount of correctly folded
protein entrapped in inactive unfolded polypeptide
molecules [6]. True active IBs, in which the majority of
the polypeptides remain active, were first reported in
early 1991 [7], and have gained more attention since
2005 [8]. In particular, when used as fusion protein
partners, the foot-and-mouth disease virus capsid pro-
tein VP1, the human b-amyloid peptide Ab42(F19D) [8],
a maltose-binding protein mutant (MalE31) [9], and the
cellulose-binding domain of Clostridium cellulovorans
(CBDclos) [10-14] have been shown to induce the
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(E. coli) with specific activities ranging from about 20%
to levels comparable with the native proteins [8,10].
These new findings have enhanced the understanding of
protein folding, and also led to several studies about
using these active inclusion bodies for immobilized bio-
catalysis [15], bioassays [13], and biomaterials [16].
In our previous study to increase the affinity of Bacil-
lus subtilis lipase A (LipA) toward hydrophobic surfaces,
we genetically attached to LipA an amphipathic helical
peptide 18A that is capable of self assembly in aqueous
solution [17,18]. Unexpectedly, the resulting fusion pro-
tein formed aggregates after being expressed in E. coli.
Subsequently, Aspergillus fumigatus amadoriase II
(AMA), Bacillus pumilus b-xylosidase (XynB), as well as
green fluorescent protein (GFP) were tested and similar
active protein aggregates with high specific activities
were found (Wu W, Xing L, Zhou B, Cai Z, Chen B, Lin
Z: Assembly of active protein aggregates in vivo induced
by terminally attached amphipathic peptide, submitted).
This serendipitous observation stimulated us to search
for more peptides which could similarly induce the for-
mation of active protein aggregates. A well-defined
self-complementary amphipathic b peptide, EAK16
(AEAEAKAKAEAEAKAK, or (AEAEAKAK)2) [19], has
attracted our attention. This peptide originates from the
Zuotin protein sequence [20], and can spontaneously
form b-sheet structure in aqueous solution with a pro-
posed pattern shown in Figure 1A [19]. In this work, we
wanted to investigate if EAK16 and one of its more
hydrophobic variant, ELK16 (LELELKLKLELELKLK, or
(LELELKLK)2), could function as an inducer for active
protein aggregate formation. Once again, the peptides
were genetically attached to the carboxyl termini of the
model proteins LipA, AMA, XynB, as well as GFP, and
the fusions were expressed in E. coli BL21 (DE3). The
fusion proteins were characterized by enzymatic activity
assays, transmission electron microscopy (TEM), laser
scanning confocal microscopy (LSCM) and Fourier
transform infrared spectroscopy (FTIR). The studies we
have performed indeed show that the terminally
attached ELK16 peptide, but not EAK16, can act as an
effective inducer for the formation of active inclusion
bodies in vivo.
Results
Active protein aggregates expressed in E. coli BL21 (DE3)
In this work, the peptide EAK16 (AEAEAKAK)2 or
ELK16 (LELELKLK)2 was terminally fused to the model
proteins including LipA, AMA, XynB, and GFP (Figure
1A). Production of the fusion proteins was induced
through the addition of isopropyl b-D-1-thiogalactopyra-
noside (IPTG). ELK16 fusion proteins were found to
express as largely inclusion bodies, without disturbing
the cell growth compared with the native proteins, as
judged from the cell density measurements (OD600)
(data not shown). On the other hand, all the EAK16
fusions were solubly expressed, with total activities and
expression levels comparable to the native counterparts
(data not shown), and thus were not further studied.
Judging from the enzyme activities in the soluble and
insoluble fractions (Figure 2), the aggregated fusion pro-
teins accounted for 87.5% of the total activity for AMA-
ELK16 and 94.4% for XynB-ELK16. Using the total
activities of the two native e n z y m e sa st h er e s p e c t i v e
benchmark, about 72% of AMA activity and 45% XynB
activity could be obtained in the form of active inclusion
bodies. Furthermore, both specific activities of the two
fusion proteins were closed to the native enzymes
(Table 1). XynB-ELK16 aggregates retained about 77%
of specific activity compared with its native counterpart,
while for AMA-ELK16 aggregates about 120%. On the
other hand, it appears that for both AMA and XynB,
the amount of ELK16 fusion produced was lower than
the native counterpart. An unexpected result was that
the LipA-ELK16 fusion was expressed in the form of
almost totally inactive inclusion bodies. It is surmised
that the addition of ELK16 might greatly influence the
folding or catalytic site of this lipase [21], which does
not contain a usual lid seen in many lipases and has a
more exposed hydrophobic active site.
The distribution of the fusion protein was also ana-
l y z e db yf l u o r e s c e n c ec o n f o cal microscopy with GFP as
the model protein, by TEM for AMA and XynB. As
shown in Figure 3, while GFP-expressing cells exhibited
uniform green fluorescence throughout the cytoplasm
(Figure 3A), an obvious localized distribution of fluores-
cence could be observed from the GFP-ELK16 cells
(Figure 3B). This observation clearly confirms the in
vivo formation of the active inclusion bodies for GFP-
ELK16, in which the GFP was fluorescent, and thus
retained the active conformation. Moreover, the TEM
image of the thin-sectioned cells expressing AMA-
ELK16 (Figure 4B) clearly shows that a large portion of
the cytoplasm was occupied by the newly formed inclu-
sion bodies [22], which was however hardly observed in
the native AMA cells (Figure 4A). A similar TEM image
was observed for XynB-ELK16, and for GFP-ELK16
(data not shown).
FTIR evidence for amyloid-like structure in the active
inclusion bodies
To confirm the existence of the hypothetic b-sheet
(Figure 1A) [19] in the ELK16 aggregates, ELK16 fusions
were analyzed by FTIR, one of the few methods avail-
able for dissecting the secondary structural information
of protein aggregates [23,24]. Generally, the amide
region I of FTIR absorbance (between 1600 cm
-1 and
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-1), as well as the secondary derivatives of the
absorbances, have been used to assign the secondary
structures [23]. For AMA (Figure 5A), the FTIR spec-
trum of AMA-ELK16 aggregates exhibits a maximum at
1643 cm
-1 (thick solid line), with a red shift of 4 cm
-1
compared with that of the native AMA (1647 cm
-1)
(thin solid line), indicating an increase in the b-sheet
component for this a/b protein [25,26]. In terms of the
secondary derivatives, peaks near 1615-1643 cm
-1,
1647-1654 cm
-1, and 1650-1660 cm
-1 are believed to be
indicative of b-sheet, random coil, and a-helical confor-
mations, respectively [23,27,28]. In particular, the pre-
sence of bands near 1621-1625 cm
-1 and 1694 cm
-1 is
considered to arise from extended antiparallel pleated
b-sheet structures [28,29]. For AMA-ELK16, new bands
appearing at 1625 cm
-1 and 1693 cm
-1 in the secondary
derivative in the ELK16 fusion (thick dashed line) are
consistent with the formation of extended antiparallel
pleated b-sheet structures in the AMA-ELK16 aggregate.
For XynB (Figure 5B), the difference between the FTIR
spectra of the native XynB and XynB-ELK16 is less dis-
tinctive. It is probably because the native XynB is an all-
b protein, with estimated 46% beta structure based on
its homology to B. subtilis XynB (PDB code: 1YIF)
(Patskovsky and Almo, unpublished data), thus the dif-
ference is more subtle [23]. Nonetheless, the shift trend
is similar. The spectra of both XynB-ELK16 and XynB
exhibit a maximum at about 1643 cm
-1, while the former
is broader. However, the secondary derivative of XynB-
ELK16 exhibits a dominant band at 1633 cm
-1 and a less
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Figure 1 Schematics for ELK16 aggregation and fusion protein constructs. (A) Antiparallel b-sheet formed by the self-complementary
EAK16 or ELK16 peptides. (B) Genetic constructs of the ELK16 fusion proteins. EAK16, (AEAEAKAK)2; ELK16, (LELELKLK)2; linker,
PTPPTTPTPPTTPTPTP; model proteins, XynB, AMA, or GFP.
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-1, while that of the native
XynB shows bands at 1637 cm
-1 and 1691 cm
-1.
Discussion
Our results clearly demonstrate that the terminally-fused
peptide ELK16 can induce the formation of active pro-
tein aggregates. Those aggregates are morphologically
similar with previously well-studied inclusion bodies in
E. coli [22], however, proteins accumulated in these
ELK16-induced inclusion bodies still largely retain their
activity. It has been reported that the assembly of the
EAK16 peptide (e.g., EAK16, ELK16, RAD16) is mainly
influenced by two factors, the ionic complementary
interactions between the negatively charged Glu or Asp
and the positively charged Lys or Arg, and the extent of
the hydrophobic residues [19,30]. While EAK16 alone
can spontaneously assemble in aqueous solution, in our
experiment it failed to induce the aggregation of target
proteins. By replacing Ala in EAK16 with the more
hydrophobic residue Leu, the resulting ELK16 peptide
successfully induced the in vivo assembly of active inclu-
sion bodies, in which extended antiparallel pleated
b-sheet structures were revealed by the FTIR analyses. It
is thus surmised that hydrophobic interactions in the
ELK16 peptide play an important role in inducing the
formation of active protein aggregates.
Since the proteins in the aggregates are active, it
implies that the secondary and tertiary structures of
the proteins must be largely preserved. Given the well-
established mechanism of the self-assembly of the
EAK16 peptide and alikes [30], as well as the existence
of amyloid-like fibrils in the Ab42 induced active inclu-
sion bodies [31], we can reasonably conclude that the
model proteins (AMA, XynB, and GFP) fold indepen-
dently of the ELK16 moiety of the fusions; the folded
model proteins however area g g r e g a t i o n - p r o n ei nt h e
cytoplasmic aqueous environment due to the attached
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Figure 2 Distributions of enzymatic activities in the soluble
and insoluble fractions of cells lysates. (A) AMA. (B) XynB. The
activities were calculated using the average of three independent
experiments and normalized to the total activities of the respective
native enzyme extracted from a same amount of cells (OD600).
Standard deviations are also showed.
Table 1 Enzymatic activities of the fusion proteins produced in E. coli
Activity (U/ml)
1
Enzymes Soluble
fraction
Insoluble
fraction
Percent of activity found
in insoluble fraction
2
Enzyme amount
(mg/ml)
3
Specific activity
(U/mg enzyme)
3
Specific activity relative
to the native enzyme
3
AMA
AMA-native 734.4 ± 37.5 9.63 ± 2.29 1.3% 0.47 1563 100%
AMA-ELK16 66.7 ± 5.1 468.7 ± 12.9 87.5% 0.25 1875 120%
XynB
XynB-native 398.8 ± 9.7 136.2 ± 17.0 25.4% 0.31 1290 100%
XynB-ELK16 13.6 ± 0.6 230.0 ± 9.8 94.4% 0.23 991 77%
1Cells were collected 6 h after IPTG induction. 1 ml soluble enzyme was extracted from 10 OD600 of cells; the insoluble fraction was also from 10 OD600 of cells
and then re-suspended in 1 ml of lysis buffer. Enzymes amounts were calculated based on SDS PAGE with serial concentrations of BSA as standards. AMA:
Aspergillus fumigatus amadoriase II; XynB: Bacillus pumilus b-xylosidase.
2The percentage of the activity found in the insoluble fraction relative to the total activity of the native or ELK16 fusion protein in the cell lysate (soluble and
insoluble fractions combined).
3For the native enzyme, the value concerns the enzyme in the soluble fraction; while for the ELK16 fusion, the value concerns the enzyme in the insoluble
fraction (more specifically, enzyme aggregate).
Figure 3 Intracellular localization of GFP-ELK16 in E. coli BL21
(DE3) cells. (A) GFP. (B) GFP-ELK16. The merged images of the
confocal fluorescent micrographs and the differential interference
contrast micrographs (DIC) are shown. Size bars, 5 μm.
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model protein “moieties” are “immobilized” by the
ELK16 moiety.
Compared with the previous reported aggregation-prone
fusion partners for active inclusion bodies formation, the
peptide ELK16 used in this work is much shorter in size,
with simpler secondary structure, and easy to modulate.
The active protein aggregates formed by the ELK16 fusion
proteins have attractive application potentials in biotech-
nology, owing to their insolubility but high activity. For
example, the ELK16 peptide-induced active aggregation
method could provide an effective way for in-situ carrier-
free enzyme immobilization and reduce the cost in other-
wise necessary enzyme concentration, purification, and
chemical immobilization steps [15], with less activity loss.
The insolubility of the ELK16 fusion proteins might also
provide a possibility for use in the production of toxic pep-
tides or proteins, for which larger fusion partners were
already attempted [32-34]. Moreover, it is possible to
develop a quick scheme for protein expression and purifi-
cation in bacteria, by adding an appropriate cleavable site
[35] between the target protein and the ELK16 peptide,
whose feasibility has already been proved in our ongoing
preliminary work. We also surmise that our observation
on this peptide-induced aggregation might provide insight
for the understanding of protein folding, misfolding and
aggregation, as well as for protein aggregation-related dis-
eases [24,36].
Conclusions
In conclusion, the self-assembling peptide ELK16 has
been employed for the first time for the production of
active inclusion bodies in E. coli, which is mostly likely
induced via the intermolecular beta structure formed by
ELK16. Due to the simplicity of this peptide and the
high efficiency of the peptide-induced aggregation, it is
of great interest to explore this approach further for
applications in protein expression, purification, and
industrial biocatalysis.
Methods
Plasmid Construction
The plasmid pET30a (+) (Novagen) was modified to
generate corresponding plasmids encoding fusions of
target proteins, PT type linker, and EXK16 (X = A or
L). The primers LipA-For (5’ACGACGACATATGGCT-
GAACACAATCCAGT 3’, the restriction site is
Figure 4 Intracellular localization of the ELK16 fusion proteins
in E. coli BL21 (DE3) cells. (A) Native AMA. (B) AMA-ELK16. The
arrow shows the newly formed inclusion body in the AMA-ELK16
cell. Size bars, 100 nm.
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Figure 5 FTIR spectra of ELK16 aggregates (thick lines) and the
respective native proteins (thin lines). The amide region I
between 1600 cm
-1 and 1700 cm
-1 for (A) AMA (B) XynB with or
without ELK16 are shown. The spectra are smoothed and scaled
independently to be full scale on the absorbance axis [25]. The
second derivatives are also showed as dashed lines.
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Page 5 of 8underlined.) and EAK-Rev (5’ TCGTTCTCGAGTCAT
TTAGCCTTGGCCTCAGCTTCCGCTTTCGCCTTCG-
CTTCTGCTTCAGCCGGCGTCGGGGTTGGGGTGG-
TTGG 3’, for EAK16) or ELK-Rev (5’ TCGTTCTCGAG
TCATTTCAGCTTTAATTCTAATTCCAGTTTTAACT
TCAGTTCAAGTTCCAGCGGCGTCGGGGTTGGGGT
GGTTGG 3’, for ELK16) were used to amplify the gene
encoding LipA-EXK16 (X = A or L) from the previously
constructed pAc18A-LipA (Wu W, Xing L, Zhou B, Cai
Z, Chen B, Lin Z: Assembly of active protein aggregates
in vivo induced by terminally attached amphipathic pep-
tide, submitted). The amplified LipA-EXK16 (X = A or
L) genes were then restriction digested with NdeIa n d
XhoI, and subcloned into the pET30a (+) vector to obtain
the pET30a-LipA-EXK16 (X = A or L) constructs.
Other constructs, including pET30a-AMA-EXK16
(X = A or L) (AMA-For: 5’ TTCTGGACATATG-
GCGGTAACCAAGTCATC 3’ and EAK-Rev or ELK-
Rev, respectively), pET30-XynB-EXK16 (X = A or L)
(primers: XynB-For 5’ ATGAGCACATATGAAGAT-
TATCAATCCAGTGCTC 3’, and EAK-Rev or ELK-Rev,
respectively), and pET30-GFP-EXK16 (X = A or L) (pri-
mers: GFP-For 5’ TTCTGGACATATGAGTAAAGGA-
GAAGAACTTT 3’, and EAK-Rev or ELK-Rev,
respectively) were similarly constructed (Figure 1B).
Fusion genes encoding the native proteins with the
hexahistidine tag at the C-termini were also similarly
amplified from the plasmids mentioned above with the
former primers and reverse primers (LipA-Rev: 5’
AAATTTAAGCTTATTCGTATTCTGGCCCCCGC-3’,
AMA-Rev: 5’ GGGAGGAAGCTTTAACTTGGAAA-
TATCTCTATAT 3’,X y n B - R e v :5 ’ GAAGAAGCTT-
TTCGTCTGTTTCCTCATAACG 3’,a n dG F P - R e v :5 ’
AAGAGAAAGCTTATTCAGCTTGGCTGCAGGTC-
GAC 3’, respectively), and subcloned into the pET30a
(+) vector.
Expression and purification of IBs
E. coli BL21 (DE3) cells were employed to express the
fusions of AMA-ELK16 and XynB-ELK16, respectively.
The expression conditions were generally similar as in
the previous 18A work (Wu W, Xing L, Zhou B, Cai Z,
Chen B, Lin Z: Assembly of active protein aggregates in
vivo induced by terminally attached amphipathic pep-
tide, submitted). In detail, the cell growth was carried
out in Luria-Bertani medium supplemented with 50 mg/L
kanamycin at 37°C with shaking (250 rpm). At an OD600
of 0.4-0.6, 0.2 mM isopropyl b-D-1-thiogalactopyranoside
(IPTG) was added to initiate the protein expression at 30°
C for another 6 h. Cells were harvested by centrifugation
at 6,000 × g for 10 min and resuspended in lysis buffer (50
mM Tris-HCl, 50 mM NaCl, 5% glycerol, pH 7.2), fol-
lowed by sonication on ice to lyse the cells thoroughly.
Centrifugation (15,000 × g for 15 min) was preformed to
separate the insoluble protein aggregates (IBs) from the
clarified soluble fractions at 4°C. IBs were washed once
with the same lysis buffer containing 0.5% (v/v) Triton X-
100 and once with lysis buffer, and finally resuspended in
t h es a m ev o l u m eo fl y s i sb u f f e r .T h ea m o u n t so ft a r g e t
proteins in both fractions were determined densitometri-
cally by denaturing polyacrylamide gel electrophoresis
( S D SP A G E )u s i n gb o v i n es e r u ma l b u m i n( B S A )a s
standard [6].
Determination of enzymatic activities in IBs
The activities of target proteins in both the soluble and
insoluble fractions were measured in 96-well microplates
with a SPECTRAMAX M2 microtiter reader (Molecular
Device, CA). In detail, the amadoriase activity was mea-
sured at 37°C by monitoring the formation of a quinone
dye following A555 (ε, 39.2 cm
2/μmol) in a peroxidase-
coupling reaction [37]. The reaction mixture contained
100 mM potassium phosphate buffer (pH 8.0), 2.7
purpurogallin units of peroxidase, 0.45 mM 4-aminoan-
tipyrine, 0.5 mM N-ethyl-N-(2-hydroxy-3-sulfopropyl)-
m-toluidine (TOOS), and 5.0 mM D-fructosyl-glycine in
a total volume of 180 μl. The b-xylosidase and lipase
assays were carried out at 37°C by monitoring the for-
mation of p-nitrophenol (pNP) following A405 (ε,
18.7 cm
2/μmol). The b-xylosidase reaction [38] was per-
formed in 180 μl reaction system (50 mM phosphate
buffer, pH 6.0, 2.5 mM p-nitrophenyl b-D-xylopyrano-
side). The lipase assay [39] was performed by addition
of 5 μl diluted enzyme into 175 μl reaction buffer
(50 mM sodium phosphate buffer, pH 8.0, 0.4 mM p-
nitrophenyl palmitate, 0.2% sodium deoxycholate, 0.1%
gum arabic). One unit of enzyme activity was defined as
the amount of enzyme that produced 1 nmol H2O2 or
p-nitrophenol per min.
Laser scanning confocal microscopic (LSCM) analyses
The cells expressing unmodified GFP or GFP-ELK16
were cultivated at 23°C for 22 h after 0.2 mM IPTG
induction. Then the cells were harvested, fixed with 4%
paraformaldehyde and photographed at 488 nm using a
Zeiss LSM 710 confocal microscope (Carl Zeiss,
Germany).
Transmission electron microscopic analyses of cells
producing ELK16 fusion proteins
Morphometric analyses of the aggregates were also per-
formed with a Hitachi H-7650B (Hitachi, Japan) trans-
mission electron microscope follow the similar sample
processing protocol as previously described (Wu W,
Xing L, Zhou B, Cai Z, Chen B, Lin Z: Assembly of
active protein aggregates in vivo induced by terminally
attached amphipathic peptide, submitted). In detail, the
cells were collected after induction of protein
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ide were used successively to fix the cells. After a
graded-ethanol serial dehydration step, the cells were
embedded in epoxy resins, sectioned, stained by uranyl
acetate solution and lead citrate, and then observed with
a Hitachi H-7650B (Hitachi, Japan) transmission elec-
tron microscope at an accelerating voltage of 80 kV.
Conformational analyses by Fourier transform infrared
spectroscopy (FTIR)
For FTIR spectroscopy analysis, the cells containing
AMA-ELK16 or XynB-ELK16 were lysed following the
lysozyme-based protocol as described previously (Wu
W, Xing L, Zhou B, Cai Z, Chen B, Lin Z: Assembly of
active protein aggregates in vivo induced by terminally
attached amphipathic peptide, submitted). Cell pellets
were resuspended using the lysis buffer, followed by
1 mg/ml lysozyme treatment and DNaseI treatment in
37°C for 1 h to lyse the cells. The IBs were then sepa-
rated by centrifugation, and washed stepwise by sterile
PBS buffer containing 0.5% (v/v) Triton X-100 and by
PBS buffer, and dried for 12 h in a Freeze-Vac system.
The FTIR absorption spectra were acquired in transmis-
sion from 4000 to 650 cm
-1 by a Nicolet Nexus 670
FTIR Spectrometer with a nitrogen-cooled, mercury -
cadmium - tellurium (MCT) detector. For each spec-
trum, 50 interferograms were collected and averaged
with 4 cm
-1 spectral resolution. The amide region I of
the IR spectra (between 1600 cm
-1 and 1700 cm
-1)w e r e
smoothed by 13 points, and scaled to be full scale on
the absorbance axis. The second derivatives of the mea-
sured absorption spectra were calculated by the
Savitzky-Golay method (3rd polynomial, 13 smoothing
points) using the OMNIC 8.0 software (Thermo Fisher
Scientific Inc.).
Acknowledgements
This work was supported by grants from the National Basic Research
Program of China (2009CB724704), the National High Tech Program of China
(2006AA020203).
Authors’ contributions
WW designed part of the experiments, performed most of the experiments,
and prepared the manuscript draft. LX and BZ participated in the enzymatic
assays and instrumental analyses. ZL conceived the study, designed and
supervised the experiments, and revised the manuscript. All authors read
and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 14 January 2011 Accepted: 15 February 2011
Published: 15 February 2011
References
1. Martinez-Alonso M, Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A:
Learning about protein solubility from bacterial inclusion bodies. Microb
Cell Fact 2009, 8:4.
2. Ventura S, Villaverde A: Protein quality in bacterial inclusion bodies.
Trends Biotechnol 2006, 24:179-185.
3. Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A: Recombinant protein
solubility - does more mean better? Nat Biotechnol 2007, 25:718-720.
4. Garcia-Fruitos E: Inclusion bodies: a new concept. Microb Cell Fact 2010,
9:80.
5. Worrall DM, Goss NH: The formation of biologically active beta-
galactosidase inclusion bodies in Escherichia coli. Aust J Biotechnol 1989,
3:28-32.
6. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R: Engineering inclusion
bodies for non denaturing extraction of functional proteins. Microb Cell
Fact 2008, 7:9.
7. Tokatlidis K, Dhurjati P, Millet J, Beguin P, Aubert JP: High activity of
inclusion bodies formed in Escherichia coli overproducing Clostridium
thermocellum endoglucanase D. FEBS Letters 1991, 282:205-208.
8. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz RM, Aris A,
Ventura S, Villaverde A: Aggregation as bacterial inclusion bodies does
not imply inactivation of enzymes and fluorescent proteins. Microb Cell
Fact 2005, 4:6.
9. Arie JP, Miot M, Sassoon N, Betton JM: Formation of active inclusion
bodies in the periplasm of Escherichia coli. Mol Microbiol 2006, 62:427-437.
10. Nahalka J, Nidetzky B: Fusion to a pull-down domain: A novel approach
of producing Trigonopsis variabilis D-amino acid oxidase as insoluble
enzyme aggregates. Biotechnol Bioeng 2007, 97:454-461.
11. Nahalka J, Vikartovska A, Hrabarova E: A crosslinked inclusion body
process for sialic acid synthesis. J Biotechnol 2008, 134:146-153.
12. Nahalka J: Physiological aggregation of maltodextrin phosphorylase from
Pyrococcus furiosus and its application in a process of batch starch
degradation to alpha-D-glucose-1-phosphate. J Ind Microbiol Biotechnol
2008, 35:219-223.
13. Nahalka J, Mislovicova D, Kavcova H: Targeting lectin activity into
inclusion bodies for the characterisation of glycoproteins. Mol Biosyst
2009, 5:819-821.
14. Nahalka J, Patoprsty V: Enzymatic synthesis of sialylation substrates
powered by a novel polyphosphate kinase (PPK3). Org Biomol Chem
2009, 7:1778-1780.
15. Roessl U, Nahalka J, Nidetzky B: Carrier-free immobilized enzymes for
biocatalysis. Biotechnol Lett 2010, 32:341-350.
16. Garcia-Fruitos E, Rodriguez-Carmona E, Diez-Gil C, Ferraz RM, Vazquez E,
Corchero JL, Cano-Sarabia M, Ratera I, Ventosa N, Veciana J, Villaverde A:
Surface cell growth engineering assisted by a novel bacterial
nanomaterial. Adv Mater 2009, 21:4249-4253.
17. Anantharamaiah GM, Jones JI, Brouillette CG, Schmidt CF, Chung BH,
Hughes TA, Bhown AS, Segrest JP: Studies of synthetic peptide analogs of
the amphipathic helix - structure of complexes with dimyristoyl
phosphatidylcholine. J Biol Chem 1985, 260:248-255.
18. Lazar KL, Miller-Auer H, Getz GS, Orgel J, Meredith SC: Helix-turn-helix
peptides that form alpha-helical fibrils: Turn sequences drive fibril
structure. Biochemistry 2005, 44:12681-12689.
19. Zhang SG, Holmes T, Lockshin C, Rich A: Spontaneous assembly of a self-
complementary oligopeptide to form a stable macroscopic membrane.
Proc Natl Acad Sci USA 1993, 90:3334-3338.
20. Zhang SG, Lockshin C, Herbert A, Winter E, Rich A: Zuotin, a putative Z-
DNA binding-protein in Saccharomyces-cerevisiae. Embo J 1992,
11:3787-3796.
21. van Pouderoyen G, Eggert T, Jaeger KE, Dijkstra BW: The crystal structure
of Bacillus subtilis lipase: A minimal alpha/beta hydrolase fold enzyme.
J Mol Biol 2001, 309:215-226.
22. Williams DC, Vanfrank RM, Muth WL, Burnett JP: Cytoplasmic inclusion-
bodies in Escherichia coli producing biosynthetic human insulin proteins.
Science 1982, 215:687-689.
23. Seshadri S, Khurana R, Fink AL: Fourier transform infrared spectroscopy in
analysis of protein deposits. In Amyloid, Prions, and Other Protein
Aggregates. Volume 309. San Diego: Academic Press Inc; 1999:559-576,
Methods in Enzymology.
24. Mitraki A: Protein aggregation: from inclusion bodies to amyloid and
biomaterials. In Advances in Protein Chemistry and Structural Biology. Volume
79. San Diego: Elsevier Academic Press Inc; 2010:89-125, Volume 79.
Advances in Protein Chemistry and Structural Biology.
25. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I,
Huang ZW, Fletterick RJ, Cohen FE, Prusiner SB: Conversion of alpha-
Wu et al. Microbial Cell Factories 2011, 10:9
http://www.microbialcellfactories.com/content/10/1/9
Page 7 of 8helices into beta-sheets features in the formation of the scrapie prion
proteins. Proc Natl Acad Sci USA 1993, 90:10962-10966.
26. Collard F, Zhang J, Nemet I, Qanungo KR, Monnier VM, Yee VC: Crystal
structure of the deglycating enzyme fructosamine oxidase (Amadoriase
II). J Biol Chem 2008, 283:27007-27016.
27. Nilsson MR: Techniques to study amyloid fibril formation in vitro.
Methods 2004, 34:151-160.
28. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S: Amyloid-
like properties of bacterial inclusion bodies. J Mol Biol 2005,
347:1025-1037.
29. Ami D, Natalello A, Taylor G, Tonon G, Doglia SM: Structural analysis of
protein inclusion bodies by Fourier transform infrared
microspectroscopy. BBA-Proteins Proteomics 2006, 1764:793-799.
30. Yang YL, Khoe U, Wang XM, Horii A, Yokoi H, Zhang SG: Designer self-
assembling peptide nanomaterials. Nano Today 2009, 4:193-210.
31. Morell M, Bravo R, Espargaro A, Sisquella X, Aviles FX, Fernandez-
Busquets X, Ventura S: Inclusion bodies: Specificity in their aggregation
process and amyloid-like structure. Biochim Biophys Acta-Mol Cell Res 2008,
1783:1815-1825.
32. Wei QD, Kim YS, Seo JH, Jang WS, Lee IH, Cha HJ: Facilitation of
expression and purification of an antimicrobial peptide by fusion with
baculoviral polyhedrin in Escherichia coli. Appl Environ Microbiol 2005,
71:5038-5043.
33. Pazgier M, Lubkowski J: Expression and purification of recombinant
human alpha-defensins in Escherichia coli. Protein Expr Purif 2006, 49:1-8.
34. Zorko M, Japelj B, Hafner-Bratkovic I, Jerala R: Expression, purification and
structural studies of a short antimicrobial peptide. Biochim Biophys Acta-
Biomembr 2009, 1788:314-323.
35. Wood DW, Wu W, Belfort G, Derbyshire V, Belfort M: A genetic system
yields self-cleaving inteins for bioseparations. Nat Biotechnol 1999,
17:889-892.
36. Serpell LC: Alzheimer’s amyloid fibrils: structure and assembly. Biochim
Biophys Acta-Mol Basis Dis 2000, 1502:16-30.
37. Zheng J, Guan H, Xu LH, Yang R, Lin ZL: Engineered amadoriase II
exhibiting expanded substrate range. Appl Microbiol Biotechnol 2010,
86:607-613.
38. Chen TJ, Zhang JQ, Liang L, Yang R, Lin ZL: An in vivo, label-free quick
assay for xylose transport in Escherichia coli. Anal Biochem 2009,
390:63-67.
39. Winkler UK, Stuckmann M: Glycogen, hyaluronate, and some other
polysaccharides greatly enhance the formation of exolipase by Serratia-
marcescens. J Bacteriol 1979, 138:663-670.
doi:10.1186/1475-2859-10-9
Cite this article as: Wu et al.: Active protein aggregates induced by
terminally attached self-assembling peptide ELK16 in Escherichia coli.
Microbial Cell Factories 2011 10:9.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wu et al. Microbial Cell Factories 2011, 10:9
http://www.microbialcellfactories.com/content/10/1/9
Page 8 of 8